Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.

导出 LinkOut

翻译打印收藏纠错

第一作者： Leonard,Moise

第一单位： EpiVax, Inc ., Providence, RI, USA.

作者： Leonard,Moise ^[1] ; Ted M,Ross ^[2] ; Daniel F,Hoft ^[3] ; William D,Martin ^[3] ; Anne S,De Groot ^[4]

作者单位： EpiVax, Inc ., Providence, RI, USA. ^[1] Institute for Immunology and Informatics, University of Rhode Island , Providence, RI, USA. ^[2] Center for Vaccines and Immunology, University of Georgia , Athens, GA, USA. ^[3] Departments of Molecular Microbiology & Immunology and Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University , St. Louis, MO, USA. ^[4]

关键词 COVID-19 SARS-CoV-2 T cell T cell epitope antibody coronavirus vaccine

主题词冠状病毒感染(Coronavirus Infections);人类(Humans);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);T淋巴细胞(T-Lymphocytes);病毒疫苗(Viral Vaccines)

DOI 10.1080/14760584.2020.1825946

PMID 32962468

发布时间 2020-12-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交